Your browser doesn't support javascript.
loading
BAYPAN study: a double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer.
Gonçalves, A; Gilabert, M; François, E; Dahan, L; Perrier, H; Lamy, R; Re, D; Largillier, R; Gasmi, M; Tchiknavorian, X; Esterni, B; Genre, D; Moureau-Zabotto, L; Giovannini, M; Seitz, J-F; Delpero, J-R; Turrini, O; Viens, P; Raoul, J-L.
Afiliação
  • Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille; Cancer Research Center of Marseille, U1068 INSERM, CNRS UMR7258; Aix-Marseille University, Marseille; Clinical Investigation Center 9502, Marseille. Electronic address: goncalvesa@marseille.fnclcc.fr.
  • Gilabert M; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille.
  • François E; Department of Medical Oncology, Centre Antoine Lacassagne, Nice.
  • Dahan L; Aix-Marseille University, Marseille; Clinical Investigation Center 9502, Marseille; Department of Digestive Oncology, Hôpital de le Timone, Assistance Publique-Hôpitaux de Marseille, Marseille.
  • Perrier H; Digestive Oncology Unit, Hôpital Saint-Joseph, Marseille.
  • Lamy R; Department of Oncology, Centre Hospitalier Bretagne Sud (Lorient), Lorient.
  • Re D; Medicine Unit, Centre Hospitalier Antibes Juan-les-Pins, Antibes.
  • Largillier R; Department of Oncology, Centre azuréen de cancérologie, Mougins.
  • Gasmi M; Department of Gastro-enterology, Hôpital Nord APHM, Marseille.
  • Tchiknavorian X; Department of Medical Oncology, Centre Hospitalier Toulon, Toulon, France.
  • Esterni B; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille; Clinical Investigation Center 9502, Marseille.
  • Genre D; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille; Clinical Investigation Center 9502, Marseille.
  • Moureau-Zabotto L; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille.
  • Giovannini M; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille.
  • Seitz JF; Aix-Marseille University, Marseille; Clinical Investigation Center 9502, Marseille; Department of Digestive Oncology, Hôpital de le Timone, Assistance Publique-Hôpitaux de Marseille, Marseille.
  • Delpero JR; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille; Cancer Research Center of Marseille, U1068 INSERM, CNRS UMR7258; Aix-Marseille University, Marseille; Clinical Investigation Center 9502, Marseille.
  • Turrini O; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille; Cancer Research Center of Marseille, U1068 INSERM, CNRS UMR7258; Aix-Marseille University, Marseille.
  • Viens P; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille; Cancer Research Center of Marseille, U1068 INSERM, CNRS UMR7258; Aix-Marseille University, Marseille; Clinical Investigation Center 9502, Marseille.
  • Raoul JL; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille; Cancer Research Center of Marseille, U1068 INSERM, CNRS UMR7258.
Ann Oncol ; 23(11): 2799-2805, 2012 Nov.
Article em En | MEDLINE | ID: mdl-22771827
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Neoplasias Pancreáticas / Compostos de Fenilureia / Protocolos de Quimioterapia Combinada Antineoplásica / Niacinamida / Desoxicitidina Tipo de estudo: Clinical_trials Idioma: En Revista: Ann Oncol Ano de publicação: 2012 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia Assunto principal: Neoplasias Pancreáticas / Compostos de Fenilureia / Protocolos de Quimioterapia Combinada Antineoplásica / Niacinamida / Desoxicitidina Tipo de estudo: Clinical_trials Idioma: En Revista: Ann Oncol Ano de publicação: 2012 Tipo de documento: Article